Silicosis classification

Jump to navigation Jump to search

Silicosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Silicosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Silicosis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Silicosis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Silicosis classification

CDC on Silicosis classification

Silicosis classification in the news

Blogs on Silicosis classification

Directions to Hospitals Treating Silicosis

Risk calculators and risk factors for Silicosis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

There are 5 subtypes of silicosis that are differentiated according to the duration of exposure, development of symptoms, pulmonary function, and findings on chest imaging. Silicosis is classified as either simple chronic, complicated chronic, interstitial pulmonary fibrosis, accelerated silicosis, or acute silicosis.

Classification

There are 5 subtypes of silicosis that are differentiated according to the duration of exposure, development of symptoms, pulmonary function, and findings on chest imaging.[1][2][3]

Subtype Simple Chronic Complicated Chronic Interstitial Pulmonary Fibrosis Accelerated Silicosis Acute Silicosis
Duration of Exposure Disease develops > 10 years following exposure to low - moderate concentrations of silica dust Disease develops > 10 years following exposure to silica dust Disease develops > 10 years following exposure to silica dust. Disease develops 5 to 10 years following high exposure to silica dust Disease develops within 5 years of exposure to extremely high concentrations of silica dust
Symptoms Often asymptomatic Dyspnea and cough Dyspnea and cough Dyspnea, weakness, and weight loss Severe, disabling dyspnea, weakness, weight loss, and progressive respiratory failure
Pulmonary Function May be either normal or reduced May be either normal or reduced May be either normal or reduced Reduced with rapid deterioration of FVC and FEV1 Reduced with restrictive changes and reduced diffusion capacity
Imaging Findings Nodules < 10 mm Nodules > 1 cm with either obstructive or restrictive changes of variable severity Diffuse reticulonodular pattern similar to idiopathic pulmonary fibrosis Rapidly progressing nodules and masses Bilateral perihilar acinar pattern consolidations with ground glass appearance

References

  1. Arakawa H, Johkoh T, Honma K, Saito Y, Fukushima Y, Shida H; et al. (2007). ; "Chronic interstitial pneumonia in silicosis and mix-dust pneumoconiosis: its prevalence and comparison of CT findings with idiopathic pulmonary fibrosis" Check |url= value (help). Chest. 131 (6): 1870–6. doi:10.1378/chest.06-2553. PMID 17400659.
  2. Park R, Rice F, Stayner L, Smith R, Gilbert S, Checkoway H (2002). ; "Exposure to crystalline silica, silicosis, and lung disease other than cancer in diatomaceous earth industry workers: a quantitative risk assessment" Check |url= value (help). Occup Environ Med. 59 (1): 36–43. PMC 1740205. PMID 11836467.
  3. Greenberg MI, Waksman J, Curtis J (2007). ; "Silicosis: a review" Check |url= value (help). Dis Mon. 53 (8): 394–416. doi:10.1016/j.disamonth.2007.09.020. PMID 17976433.

Template:WH Template:WS